1981
DOI: 10.1016/0091-6749(81)90132-9
|View full text |Cite
|
Sign up to set email alerts
|

Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
242
1
9

Year Published

1983
1983
2008
2008

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 708 publications
(258 citation statements)
references
References 30 publications
3
242
1
9
Order By: Relevance
“…It is well-known that allergen bronchoprovocation in patients with asthma produces a biphasic response consisting of immediate bronchospasm which almost resolves within minutes and can be prevented by treatment with f2-adrenoceptor agonists. Some minutes after exposure to the allergen, a late episode of bronchoconstriction can also occur, which is more severe than the immediate response and which is resistant to treatment with f32-adrenoceptor agonists (Hargreaves et al, 1981;Paggiaro et al, 1991). These early and late responses are associated with a marked inflammatory reaction in the airways as a result of the release of distinct mediators and activation of different types of immune cells (O'Byrne et al, 1987;Schlosberg et al, 1993).…”
Section: Introductionmentioning
confidence: 99%
“…It is well-known that allergen bronchoprovocation in patients with asthma produces a biphasic response consisting of immediate bronchospasm which almost resolves within minutes and can be prevented by treatment with f2-adrenoceptor agonists. Some minutes after exposure to the allergen, a late episode of bronchoconstriction can also occur, which is more severe than the immediate response and which is resistant to treatment with f32-adrenoceptor agonists (Hargreaves et al, 1981;Paggiaro et al, 1991). These early and late responses are associated with a marked inflammatory reaction in the airways as a result of the release of distinct mediators and activation of different types of immune cells (O'Byrne et al, 1987;Schlosberg et al, 1993).…”
Section: Introductionmentioning
confidence: 99%
“…Bronchial responsiveness to histamine or methacholine assessed in challenge testing is considered an objective measure for bronchial lability [1]. Bronchial responsiveness is related to the presence of respiratory symptoms [2][3][4], asthma [5], and the severity of asthma [1].…”
mentioning
confidence: 99%
“…Bronchial responsiveness is related to the presence of respiratory symptoms [2][3][4], asthma [5], and the severity of asthma [1]. It is also frequently expressed in established chronic obstructive pulmonary disease (COPD) [6], and is an important risk factor for the development of airway obstruction [7].…”
mentioning
confidence: 99%
“…Other methods of expressing the response to bronchial challenge include the DRS [15], and the bronchial responsiveness index (BRindex), de®ned as the log of the slope of the percentage decline from baseline FEV 1 after the last dose per unit dose of methacholine [16]. These latter two methods may be more useful in epidemiological studies because a value that related well to symptom history can be calculated for the entire sample, even if the subject does not experience a 20% drop in FEV 1 . In this study, the DRS as well as the positive rate of MBPT were used to evaluate the bronchial responsiveness.…”
Section: Discussionmentioning
confidence: 99%